Tapewire

Nasdaq · USD

ABEO

ABEONA THERAPEUTICS INC.

Export transactions ↓
Tapewire entity
5808
SEC CIK
0000318306
Parsed reports
305

Last 12 months

Inside the activity.

0 purchase rows · 34 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202501
Jan 202605
Feb 202605
Mar 202602
Apr 202600
May 202603
Jun 2026011
Jul 202605
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 14, 2023 Filed Jun 16, 2023 20:05 UTC
Alland LeilaDirector
GrantCommon Stock 58,689 $4.62 $271,143.18
Disclosure

SEC source: 0001493152-23-021651 · ownership.xml · nonDerivative · entry 1

Alland Leila · CIK 0001825216 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,103

F1 · shares: All of the restricted stock will vest on June 14, 2024.

Read SEC document
June 05, 2023 Filed Jun 7, 2023 20:15 UTC
Seshadri VishwasDirector · Chief Executive Officer
GrantCommon Stock 336,826 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-020417 · ownership.xml · nonDerivative · entry 1

Seshadri Vishwas · CIK 0001865131 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 501,731

F1 · shares: The restricted stock will vest one-third on each of June 5, 2024, June 5, 2025 and June 5, 2026.

Read SEC document
June 05, 2023 Filed Jun 7, 2023 20:15 UTC
Vazzano Joseph WalterChief Financial Officer
GrantCommon stock 141,908 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-020416 · ownership.xml · nonDerivative · entry 1

Vazzano Joseph Walter · CIK 0001715291 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 236,366

F1 · shares: The restricted stock will vest one-third on each of June 5, 2024, June 5, 2025 and June 5, 2026.

Read SEC document
June 05, 2023 Filed Jun 7, 2023 20:15 UTC
O'Malley Brendan M.SVP, General Counsel
GrantCommon stock 90,902 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-020415 · ownership.xml · nonDerivative · entry 1

O'Malley Brendan M. · CIK 0001884342 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,421

F1 · shares: The restricted stock will vest one-third on each of June 5, 2024, June 5, 2025 and June 5, 2026.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 20:15 UTC
Seshadri VishwasDirector · Chief Executive Officer
Tax withholdingCommon Stock 827 $3.06 $2,530.62
Disclosure

SEC source: 0001493152-23-020291 · ownership.xml · nonDerivative · entry 1

Seshadri Vishwas · CIK 0001865131 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,905

F1 · shares: Represents the number of shares that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock and does not represent a sale. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e).

Read SEC document
April 25, 2023 Filed May 5, 2023 20:05 UTC
Alvino MarkDirector
SaleCommon Stock 887 $3.25 $2,882.75
Disclosure

SEC source: 0001493152-23-015587 · ownership.xml · nonDerivative · entry 1

Alvino Mark · CIK 0001356828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,527

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:23 UTC
O'Malley Brendan M.SVP, General Counsel
Tax withholdingCommon stock 104 $2.82 $293.28
Disclosure

SEC source: 0001493152-23-011036 · ownership.xml · nonDerivative · entry 1

O'Malley Brendan M. · CIK 0001884342 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,519

F1 · kind: Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e).

Read SEC document
March 20, 2023 Filed Mar 21, 2023 21:13 UTC SaleCommon Stock 268 $2.33 $624.44
Disclosure

SEC source: 0001493152-23-008429 · ownership.xml · nonDerivative · entry 1

Amoroso Michael · CIK 0001830874 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,441

F1 · acquired: The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:05 UTC
Vazzano Joseph WalterChief Financial Officer
Tax withholdingCommon stock 792 $2.60 $2,059.20
Disclosure

SEC source: 0001493152-23-008076 · ownership.xml · nonDerivative · entry 1

Vazzano Joseph Walter · CIK 0001715291 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,458

F1 · kind: Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e).

Read SEC document
March 03, 2023 Filed Mar 4, 2023 00:06 UTC SaleCommon Stock 1,002 $2.38 $2,384.76
Disclosure

SEC source: 0001493152-23-006716 · ownership.xml · nonDerivative · entry 1

Amoroso Michael · CIK 0001830874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,709

F1 · kind: The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards.

Read SEC document
March 03, 2023 Filed Mar 4, 2023 00:00 UTC
O'Malley Brendan M.SVP, General Counsel
Tax withholdingCommon stock 207 $2.28 $471.96
Disclosure

SEC source: 0001493152-23-006714 · ownership.xml · nonDerivative · entry 1

O'Malley Brendan M. · CIK 0001884342 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,623

F1 · kind: Represents shares of restricted stock surrendered to satisfy the reporting person's tax withholding obligation upon vesting of restricted stock. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e).

Read SEC document
December 09, 2022 Filed Dec 12, 2022 21:10 UTC
O'Malley Brendan M.SVP, General Counsel
PurchaseCommon stock 5,869 $3.13 $18,369.97
Disclosure

SEC source: 0001493152-22-035169 · ownership.xml · nonDerivative · entry 1

O'Malley Brendan M. · CIK 0001884342 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,830

Read SEC document
November 18, 2022 Filed Nov 21, 2022 14:00 UTC
Vazzano Joseph WalterChief Financial Officer
PurchaseCommon stock 2,500 $4.00 $10,000.00
Disclosure

SEC source: 0001493152-22-033018 · ownership.xml · nonDerivative · entry 1

Vazzano Joseph Walter · CIK 0001715291 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,250

Read SEC document
November 18, 2022 Filed Nov 21, 2022 14:00 UTC
O'Malley Brendan M.SVP, General Counsel
PurchaseCommon stock 7,500 $3.99 $29,925.00
Disclosure

SEC source: 0001493152-22-033016 · ownership.xml · nonDerivative · entry 1

O'Malley Brendan M. · CIK 0001884342 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,961

Read SEC document
October 17, 2022 Filed Oct 18, 2022 20:05 UTC
Seshadri VishwasDirector · Chief Executive Officer
Tax withholdingCommon Stock 207 $4.30 $890.10
Disclosure

SEC source: 0001493152-22-028650 · ownership.xml · nonDerivative · entry 1

Seshadri Vishwas · CIK 0001865131 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,732

F1 · shares: Represents the number of shares that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock and does not represent a sale.

Read SEC document
September 28, 2022 Filed Sep 30, 2022 20:05 UTC
Seshadri VishwasDirector · Chief Executive Officer
GrantCommon Stock 155,200 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-027279 · ownership.xml · nonDerivative · entry 1

Seshadri Vishwas · CIK 0001865131 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,939

F1 · shares: The restricted stock will vest 25% on each of September 28, 2023, September 28, 2024, September 28, 2025 and September 28, 2026.

Read SEC document
September 28, 2022 Filed Sep 30, 2022 20:05 UTC
O'Malley Brendan M.SVP, General Counsel
GrantCommon stock 72,750 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-027280 · ownership.xml · nonDerivative · entry 1

O'Malley Brendan M. · CIK 0001884342 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,461

F1 · shares: The restricted stock will vest 25% on each of September 28, 2023, September 28, 2024, September 28, 2025 and September 28, 2026.

F2 · balance_after: On September 22, 2022, the reporting person filed a Form 4 that inadvertently reported an additional 1,360 shares of common stock as beneficially owned in Column 5. The amount disclosed in Column 5 above rectifies that error.

Read SEC document
September 28, 2022 Filed Sep 30, 2022 20:05 UTC
Vazzano Joseph WalterChief Financial Officer
GrantCommon stock 72,750 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-027277 · ownership.xml · nonDerivative · entry 1

Vazzano Joseph Walter · CIK 0001715291 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,750

F1 · shares: The restricted stock will vest 25% on each of September 28, 2023, September 28, 2024, September 28, 2025 and September 28, 2026.

Read SEC document
September 26, 2022 Filed Sep 28, 2022 20:39 UTC
Alland LeilaDirector
GrantCommon Stock 13,400 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-027052 · ownership.xml · nonDerivative · entry 1

Alland Leila · CIK 0001825216 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,414

F1 · shares: All of the restricted stock will vest on September 26, 2023.

F2 · balance_after: On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split.

Read SEC document
September 26, 2022 Filed Sep 28, 2022 20:41 UTC GrantCommon Stock 13,400 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-027054 · ownership.xml · nonDerivative · entry 1

Charles Faith L. · CIK 0001853985 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,414

F1 · shares: All of the restricted stock will vest on September 26, 2023.

F2 · balance_after: On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split.

Read SEC document
September 26, 2022 Filed Sep 28, 2022 20:38 UTC GrantCommon Stock 13,400 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-027051 · ownership.xml · nonDerivative · entry 1

Silverstein Christine Berni · CIK 0001772546 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,525

F1 · shares: All of the restricted stock will vest on September 26, 2023.

F2 · balance_after: On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split.

Read SEC document
September 26, 2022 Filed Sep 28, 2022 20:36 UTC GrantCommon Stock 13,400 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-027048 · ownership.xml · nonDerivative · entry 1

Amoroso Michael · CIK 0001830874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,711

F1 · shares: All of the restricted stock will vest on September 26, 2023.

F2 · balance_after: On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split.

Read SEC document
September 26, 2022 Filed Sep 28, 2022 20:36 UTC
Wider ToddDirector
GrantCommon Stock 13,400 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-027047 · ownership.xml · nonDerivative · entry 1

Wider Todd · CIK 0001642715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,907

F1 · shares: All of the restricted stock will vest on September 26, 2023.

F2 · balance_after: On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split.

Read SEC document
September 26, 2022 Filed Sep 28, 2022 20:34 UTC GrantCommon Stock 13,400 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-027045 · ownership.xml · nonDerivative · entry 1

Mann Paul Elliot · CIK 0001744816 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,907

F1 · shares: All of the restricted stock will vest on September 26, 2023.

F2 · balance_after: On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split.

Read SEC document
September 26, 2022 Filed Sep 28, 2022 20:33 UTC
Alvino MarkDirector
GrantCommon Stock 13,400 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-027042 · ownership.xml · nonDerivative · entry 1

Alvino Mark · CIK 0001356828 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,414

F1 · shares: All of the restricted stock will vest on September 26, 2023.

F2 · balance_after: On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split.

Read SEC document
September 26, 2022 Filed Sep 28, 2022 20:32 UTC GrantCommon Stock 13,400 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-027041 · ownership.xml · nonDerivative · entry 1

Wuchterl Donald A. · CIK 0001857854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,414

F1 · shares: All of the restricted stock will vest on September 26, 2023.

F2 · balance_after: On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split.

Read SEC document
September 21, 2022 Filed Sep 22, 2022 20:36 UTC
O'Malley Brendan M.SVP, General Counsel
Tax withholdingCommon stock 479 $3.72 $1,781.88
Disclosure

SEC source: 0001493152-22-026569 · ownership.xml · nonDerivative · entry 1

O'Malley Brendan M. · CIK 0001884342 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,071

F1 · kind: Represents the number of shares that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock and does not represent a sale.

Read SEC document
July 21, 2022 Filed Jul 25, 2022 22:17 UTC
Vazzano Joseph WalterChief Financial Officer
GrantCommon stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-020281 · ownership.xml · nonDerivative · entry 1

Vazzano Joseph Walter · CIK 0001715291 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

F1 · shares: The restricted stock will vest 25% on each of July 21, 2023, July 21, 2024, July 21, 2025 and July 21, 2026.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:17 UTC
Alvino MarkDirector
SaleCommon Stock 20,000 $0.15 $3,098.00
Disclosure

SEC source: 0001493152-22-017168 · ownership.xml · nonDerivative · entry 1

Alvino Mark · CIK 0001356828 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,181

F1 · price: Reflects the average weighted price of sales on June 15, 2022. The shares were sold in multiple transactions at prices ranging from $0.152 to $0.157, inclusive. The reporting person undertakes to provide Abeona Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Read SEC document
June 06, 2022 Filed Jun 7, 2022 20:05 UTC
Alvino MarkDirector
SaleCommon Stock 35,000 $0.16 $5,463.50
Disclosure

SEC source: 0001493152-22-016079 · ownership.xml · nonDerivative · entry 1

Alvino Mark · CIK 0001356828 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,181

F1 · price: Reflects the average weighted price of sales on June 6, 2022. The shares were sold in multiple transactions at prices ranging from $0.155 to $0.1617, inclusive. The reporting person undertakes to provide Abeona Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Read SEC document
June 01, 2022 Filed Jun 17, 2022 20:13 UTC
Seshadri VishwasDirector · Chief Executive Officer
Tax withholdingCommon Stock 81,525 $0.16 $13,044.00
Disclosure

SEC source: 0001493152-22-017159 · ownership.xml · nonDerivative · entry 1

Seshadri Vishwas · CIK 0001865131 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,475

F1 · kind: Represents the number of shares of that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock and does not represent a sale.

Read SEC document
March 14, 2022 Filed Mar 16, 2022 20:08 UTC
Vazzano Joseph WalterChief Financial Officer
GrantCommon stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-006976 · ownership.xml · nonDerivative · entry 1

Vazzano Joseph Walter · CIK 0001715291 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

F1 · shares: The restricted stock will vest 25% on each of March 14, 2023, March 14, 2024, March 14, 2025 and March 14, 2026.

Read SEC document
December 06, 2021 Filed Dec 9, 2021 00:05 UTC
O'Malley Brendan M.SVP, General Counsel
SaleCommon stock 8,880 $0.57 $5,034.96
Disclosure

SEC source: 0001493152-21-030876 · ownership.xml · nonDerivative · entry 1

O'Malley Brendan M. · CIK 0001884342 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,750

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Brendan O'Malley on February 24, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.56 to $0.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.

Read SEC document
November 05, 2021 Filed Nov 5, 2021 23:00 UTC
O'Malley Brendan M.SVP, General Counsel
SaleCommon stock 8,880 $0.89 $7,894.32
Disclosure

SEC source: 0001493152-21-027433 · ownership.xml · nonDerivative · entry 1

O'Malley Brendan M. · CIK 0001884342 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,630

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Brendan O'Malley on February 24, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.8801 to $0.9038, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.

Read SEC document
October 15, 2021 Filed Oct 18, 2021 20:05 UTC
Seshadri VishwasDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 300,000 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001493152-21-025690 · ownership.xml · derivative · entry 2

Seshadri Vishwas · CIK 0001865131 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2031-10-15

F2 · derivative.exercise_date: The options will vest 25% on October 15, 2022, and in 36 equal monthly installments thereafter.

Read SEC document
October 15, 2021 Filed Oct 18, 2021 20:05 UTC
Seshadri VishwasDirector · Chief Executive Officer
GrantCommon stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-025690 · ownership.xml · nonDerivative · entry 1

Seshadri Vishwas · CIK 0001865131 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,000

F1 · shares: The restricted stock will vest 25% on each of October 15, 2022, October 15, 2023, October 15, 2024 and October 15, 2025.

Read SEC document
October 11, 2021 Filed Oct 13, 2021 23:08 UTC
O'Malley Brendan M.SVP, General Counsel
SaleCommon stock 25,734 $0.90 $23,271.26
Disclosure

SEC source: 0001493152-21-025348 · ownership.xml · nonDerivative · entry 1

O'Malley Brendan M. · CIK 0001884342 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 222,510

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Brendan O'Malley on February 24, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.89 to $0.9625, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.

Read SEC document
October 08, 2021 Filed Oct 9, 2021 00:31 UTC
O'Malley Brendan M.SVP, General Counsel
SaleCommon stock 22,763 $1.05 $23,914.81
Disclosure

SEC source: 0001493152-21-025084 · ownership.xml · nonDerivative · entry 2

O'Malley Brendan M. · CIK 0001884342 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 248,244

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Brendan O'Malley on February 24, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.84 to $1.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.

Read SEC document
October 08, 2021 Filed Oct 9, 2021 00:29 UTC
CARR EDWARDChief Financial Officer
SaleCommon stock 29,122 $1.05 $30,595.57
Disclosure

SEC source: 0001493152-21-025082 · ownership.xml · nonDerivative · entry 1

CARR EDWARD · CIK 0001273351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,169

F1 · kind: The sales reported in this Form 4 were used solely to cover tax obligations associated with vested restricted stock awards and were effected pursuant to a Rule 10b5-1 trading plan adopted by Edward Carr on February 23, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.84 to $1.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.

Read SEC document
October 07, 2021 Filed Oct 9, 2021 00:33 UTC
Wider ToddDirector
SaleCommon Stock 25,000 $0.97 $24,150.00
Disclosure

SEC source: 0001493152-21-025086 · ownership.xml · nonDerivative · entry 1

Wider Todd · CIK 0001642715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.9624 to $0.9661, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.

Read SEC document
October 05, 2021 Filed Oct 9, 2021 00:31 UTC
O'Malley Brendan M.SVP, General Counsel
SaleCommon stock 2,447 $1.05 $2,569.35
Disclosure

SEC source: 0001493152-21-025084 · ownership.xml · nonDerivative · entry 1

O'Malley Brendan M. · CIK 0001884342 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,007

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Brendan O'Malley on February 24, 2021.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 20:06 UTC
Amoroso MichaelDirector · Chief Executive Officer
SaleCommon stock 45,409 $1.09 $49,382.29
Disclosure

SEC source: 0001493152-21-024499 · ownership.xml · nonDerivative · entry 1

Amoroso Michael · CIK 0001830874 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 604,637

F1 · kind: The sales reported in this Form 4 were to cover tax obligations associated with vested restricted stock awards and were effected pursuant to a Rule 10b5-1 trading plan adopted by Michael Amoroso on February 24, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.08 to $1.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.

Read SEC document
September 20, 2021 Filed Sep 22, 2021 21:37 UTC
O'Malley Brendan M.SVP, General Counsel
GrantStock Option (right to buy) · Derivative 272,000 $0.00 Strike: $1.21 $0.00
Disclosure

SEC source: 0001493152-21-023408 · ownership.xml · derivative · entry 2

O'Malley Brendan M. · CIK 0001884342 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,000

Underlying: Common Stock · 272,000 shares

Expires 2031-09-20

F2 · derivative.exercise_date: The options will vest 25% on September 20, 2022, and in 36 equal monthly installments thereafter.

Read SEC document
September 20, 2021 Filed Sep 22, 2021 21:37 UTC
O'Malley Brendan M.SVP, General Counsel
GrantCommon stock 136,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-023408 · ownership.xml · nonDerivative · entry 1

O'Malley Brendan M. · CIK 0001884342 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,454

F1 · shares: The restricted stock will vest 25% on each of September 20, 2022, September 20, 2023, September 20, 2024 and September 20, 2025.

Read SEC document
August 10, 2021 Filed Aug 12, 2021 20:05 UTC
CARR EDWARDChief Financial Officer
GrantStock Option (right to buy) · Derivative 476,000 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0001493152-21-019498 · ownership.xml · derivative · entry 2

CARR EDWARD · CIK 0001273351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 476,000

Underlying: Common Stock · 476,000 shares

Expires 2031-08-10

F2 · derivative.exercise_date: The options will vest 25% on August 10, 2022, and in 36 equal monthly installments thereafter.

Read SEC document
August 10, 2021 Filed Aug 12, 2021 20:05 UTC
CARR EDWARDChief Financial Officer
GrantCommon stock 238,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-21-019498 · ownership.xml · nonDerivative · entry 1

CARR EDWARD · CIK 0001273351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 429,291

F1 · shares: The restricted stock will vest 25% on each of August 10, 2022, August 10, 2023, August 10, 2024 and August 10, 2025.

Read SEC document
June 01, 2021 Filed Jun 4, 2021 01:06 UTC
Seshadri VishwasSVP, Head of Res./Clin. Dev.
GrantStock Option (right to buy) · Derivative 400,000 $0.00 Strike: $1.71 $0.00
Disclosure

SEC source: 0001567619-21-011667 · doc1.xml · derivative · entry 3

Seshadri Vishwas · CIK 0001865131 · SVP, Head of Res./Clin. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2031-06-01

F3 · derivative.exercise_date: The options will vest 25% on June 1, 2022, and in 36 equal monthly installments thereafter.

Read SEC document
June 01, 2021 Filed Jun 4, 2021 01:06 UTC
Seshadri VishwasSVP, Head of Res./Clin. Dev.
GrantCommon stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-011667 · doc1.xml · nonDerivative · entry 2

Seshadri Vishwas · CIK 0001865131 · SVP, Head of Res./Clin. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

F2 · shares: The restricted stock will vest 100% on each of June 1, 2022.

Read SEC document
June 01, 2021 Filed Jun 4, 2021 01:06 UTC
Seshadri VishwasSVP, Head of Res./Clin. Dev.
GrantCommon stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-011667 · doc1.xml · nonDerivative · entry 1

Seshadri Vishwas · CIK 0001865131 · SVP, Head of Res./Clin. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

F1 · shares: The restricted stock will vest 25% on each of June 1, 2022, June 1, 2023, June 1, 2024 and June 1, 2025.

Read SEC document
May 25, 2021 Filed May 28, 2021 01:52 UTC GrantStock Option (right to buy) · Derivative 98,168 $0.00 Strike: $1.49 $0.00
Disclosure

SEC source: 0001493152-21-013130 · ownership.xml · derivative · entry 2

Wuchterl Donald A. · CIK 0001857854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,168

Underlying: Common Stock · 98,168 shares

Expires 2031-05-25

F2 · derivative.exercise_date: All of the stock options will vest on November 25, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.